Kuala Lumpur, 13 October 2010 – Malaysian Genomics Resource Centre Berhad (“MGRC” or the “Company”), Malaysia’s newly-listed genome sequencing and analysis service provider, announced today the appointment of Dr Stephen Rudd to the position of Chief Scientific Officer.

Dr Rudd specialises in bioinformatics and has been actively involved in projects relating to genome analysis, gene expression profiling, proteomics, toxicogenomics and pharmacogenomics. His primary responsibilities in MGRC include overseeing the development of new services and analysis pipelines.

Managing Director Robert Hercus said, “We are very pleased to welcome Dr Rudd, who is a highly experienced bioinformatician. In addition to our existing team of bioinformatics experts, I am confident that Dr Rudd will help to increase our capacity to take on new projects in genomics and bioinformatics.”

Dr Rudd said, “It is such a great opportunity for me to be working in Malaysia and especially with a company like MGRC. Over the years MGRC has successfully established itself as a proven and trusted player on the global bioinformatics stage. I am highly optimistic that MGRC will become a household name in the genomics and life science industry and I am looking forward to being part of the Company.”

Dr Rudd has a Ph.D. in molecular biology from the University of East Anglia in the UK. He was a Senior Bioinformatics Specialist at Orion Pharma in Finland. Prior to that, he was the Senior Scientist and the Head of Bioinformatics at the Turku Centre for Biotechnology in Finland. His other previous attachments include the John Innes Centre in the UK and GSF Research Centre in Munich, Germany. He has published more than 40 scientific articles, and co-authored the research paper on the Arabidopsis thaliana genome, the first plant genome in the world to be sequenced.